Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of HSK31858 in non-cystic fibrosis bronchiectasis
CTR20243623Phase 3Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HSK31858 in bronchiectasis, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Sep 2024; status: active.
02
Drugs
HSK31858
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on CTR20243623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243623.